Prevalence and Risk Factors of Type 2 Diabetes Mellitus Among Hepatitis B Virus Patients: A Large Retrospective Cohort Study

被引:0
作者
Abu Baker, Fadi [1 ]
Zeina, Abdel-Rauf [1 ,2 ,3 ]
Natour, Randa Taher [1 ]
Abu Mouch, Saif [3 ,4 ]
Kopelman, Yael [1 ]
Shibolet, Oren [5 ,6 ]
Israel, Ariel [7 ,8 ]
机构
[1] Hillel Yaffe Med Ctr, Dept Gastroenterol & Hepatol, Hadera, Israel
[2] Hillel Yaffe Med Ctr, Dept Radiol, Hadera, Israel
[3] Technion Fac Med, Haifa, Israel
[4] Hillel Yaffe Med Ctr, Dept Internal Med B, Hadera, Israel
[5] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol & Hepatol, Tel Aviv, Israel
[6] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[7] Tel Aviv Univ, Res Inst, Fac Med & Hlth Sci, Leumit Hlth Serv,Sch Publ Hlth, Tel Aviv, Israel
[8] Tel Aviv Univ, Fac Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2025年 / 22卷 / 03期
关键词
Hepatitis B virus; type 2 diabetes mellitus; screening; prevalence; risk factors; METABOLIC SYNDROME; INFECTION; ASSOCIATION;
D O I
10.7150/ijms.104839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hepatitis B virus (HBV) infection and type 2 diabetes mellitus (T2DM) are both major health burdens worldwide. There is a suspected link between the two conditions, but the nature of the relationship is not well understood. This study aimed to investigate the prevalence of T2DM in patients with HBV, compared to matched non-HBV patients. Methods: A retrospective cohort study was conducted using data from the Leumit-Health-Service (LHS) database, a major health insurance provider in Israel, covering the years 2000-2020. The study included patients with HBV infection and matched controls using propensity score matching. T2DM's prevalence was assessed and compared between both groups. Results: A total of 3,436 HBV carriers and 34,360 matched controls were included. T2DM's prevalence was significantly higher among HBV patients compared to the control group (22.1% vs. 19.5%; P<0.001). Through multivariate analysis, we identified age, obesity, smoking, and specific HBV-related parameters, such as chronic active disease or evidence of advanced fibrosis at presentation, as independent risk factors for T2DM in HBV patients. Conclusions: This study revealed a higher prevalence of T2DM in HBV patients compared to controls, and identified specific risk factors associated with T2DM in HBV patients. Enhanced screening and management of metabolic risk factors should be considered in this population.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 26 条
  • [21] Reilly Meredith L, 2012, J Diabetes Sci Technol, V6, P858
  • [22] Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta-analysis
    Shen, Yi
    Zhang, Sheng
    Wang, Xulin
    Wang, Yuanyuan
    Zhang, Jian
    Qin, Gang
    Li, Wenchao
    Ding, Kun
    Zhang, Lei
    Liang, Feng
    [J]. LIVER INTERNATIONAL, 2017, 37 (10) : 1451 - 1460
  • [23] Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
    Shi, Yi-Xian
    Huang, Chen-Jie
    Yang, Zheng-Gang
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (36) : 8161 - 8167
  • [24] Hepatitis B Virus X Protein Regulates Hepatic Glucose Homeostasis via Activation of Inducible Nitric Oxide Synthase
    Shin, Hye-Jun
    Park, Young-Ho
    Kim, Sun-Uk
    Moon, Hyung-Bae
    Park, Do Sim
    Han, Ying-Hao
    Lee, Chul-Ho
    Lee, Dong-Seok
    Song, In-Sung
    Lee, Dae Ho
    Kim, Minhye
    Kim, Nam-Soon
    Kim, Dae-Ghon
    Kim, Jin-Man
    Kim, Sang-Keun
    Kim, Yo Na
    Kim, Su Sung
    Choi, Cheol Soo
    Kim, Young-Bum
    Yu, Dae-Yeul
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (34) : 29872 - 29881
  • [25] Immune response pattern varies with the natural history of chronic hepatitis B
    Wang, Wen-Tao
    Zhao, Xue-Qi
    Li, Gui-Ping
    Chen, Yi-Zhi
    Wang, Lin
    Han, Mei-Fang
    Li, Wei-Na
    Chen, Tao
    Chen, Guang
    Xu, Dong
    Ning, Qin
    Zhao, Xi-Ping
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (16) : 1950 - 1963
  • [26] Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
    Wild, S
    Roglic, G
    Green, A
    Sicree, R
    King, H
    [J]. DIABETES CARE, 2004, 27 (05) : 1047 - 1053